Here’s the latest I can share based on trusted public reporting:
- In 2026, there was a nationwide recall of a specific batch of Xanax XR (extended-release) tablets due to dissolution testing failures. The recall was initiated by the manufacturer and classified by the FDA as a Class II recall, indicating potential but not definitive health risk, with the risk framed as temporary or reversible [web sources discussing the 2026 Xanax XR recall].
- Reports indicate the recall affected one lot of 3 mg Xanax XR tablets distributed in the US between 2024 and 2025, with bottles labeled and expiring in 2027. The concern centers on insufficient dissolution, which could reduce effectiveness or alter dosing, though no adverse events were widely reported at the outset [web sources from 2026 coverage].
- Coverage from multiple outlets notes patients should check their bottle’s lot number and expiration date to determine if they’re affected, and to follow FDA/manufacturer guidance for replacements or refunds. Some outlets also describe the recall as a focused, lot-specific action rather than a broad market withdrawal [web sources from 2026 coverage].
What this means for you
- If you are in Piscataway, NJ (your location), or anywhere in the US, check the Xanax XR bottle(s) for the specific lot number and expiration date cited by the recall notices (the affected lot is identified by the manufacturer and FDA in official communications). If your bottle matches, contact the pharmacist or the manufacturer for instructions, including potential returns or replacements [web sources from 2026 coverage].
- If you don’t see the affected lot on your Xanax XR, there’s no immediate action recommended beyond standard medication safety practices. Always store medications as directed and consult your prescribing clinician if you notice changes in effect, timing, or if you have concerns about your current supply [web sources from 2026 coverage].
Citations
- Reports detailing the 2026 Xanax XR recall and FDA classification as a Class II recall, with emphasis on dissolution issues and lot-specific scope.[3][4][5]
- Additional coverage noting the focus on a single lot with distribution details and guidance for patients.[7][8]
- Public-facing explainers about how to identify if you’re affected and next steps.[9]
If you want, I can look up the exact lot numbers and give you step-by-step instructions on checking your current Xanax XR supply and contacting the manufacturer or your pharmacy.
Sources
A specific type of the anti-anxiety drug failed dissolution tests, which indicates its effectiveness could be altered, according to the FDA.
www.today.comA form of prescription Xanax have been recalled nationwide, according to the Food and Drug Administration (FDA). 60-tablet bottles of Xanax XR extended-release tablets are now recalled nationwide as of Wednesday, April 15.
people.comA nationwide recall has been issued for a specific lot of Xanax XR, a commonly prescribed anxiety medication, after federal regulators and the drug’s manufacturer flagged a manufacturing issue involving how the tablets dissolve in the body.
ground.newsThe FDA has recalled one lot of Xanax XR bottles for failing dissolution standards. (Adobe Stock)
www.khou.comMylan Pharmaceuticals is pulling one lot of Xanax from pharmacy shelves nationwide because of what the company said is "the potential presence of a foreign substance" in the popular prescription anti-anxiety drug.
www.cbsnews.comDrugmaker Mylan cites risk of infection from unnamed "foreign material" in the popular prescription anti-anxiety drug
www.cbsnews.comNationwide recall targets one Xanax XR lot after failed dissolution testing. Here's what patients should check and do next now.
freedomforallamericans.org